Limours, France

Jaime Francisco Angulo-Mora

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jaime Francisco Angulo-Mora: Innovator in Pharmaceutical Technologies

Introduction

Jaime Francisco Angulo-Mora is a notable inventor based in Limours, France. He has made significant contributions to the field of pharmaceutical technologies, particularly in the development of innovative systems for drug delivery and gene expression.

Latest Patents

Angulo-Mora holds 2 patents that showcase his expertise. His first patent, titled "Use of a reverse-micellar system for delivering chelators of radionuclides and metals," involves reverse-micellar systems that include an active agent, acylglycerol, sterol, lecithin, ethanol, and water. This invention is aimed at chelation and sequestering of radionuclides and metals in patients. His second patent, "Stable and long-lasting siRNA expression vectors and the applications thereof," describes a siRNA expression vector designed to inhibit or eliminate the expression of target genes in mammalian cells. This vector comprises various components, including a bacterial cassette and a siRNA transcription cassette, which are crucial for effective gene regulation.

Career Highlights

Throughout his career, Angulo-Mora has worked with prominent organizations such as Medesis Pharma and the Commissariat à l'Énergie Atomique. His work in these companies has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Angulo-Mora has collaborated with talented individuals in his field, including Caroline Bauer and Elsa Compte. These collaborations have further enriched his research and innovation efforts.

Conclusion

Jaime Francisco Angulo-Mora is a distinguished inventor whose work in pharmaceutical technologies has led to significant advancements in drug delivery and gene expression systems. His patents reflect his commitment to innovation and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…